Stocks · Health care · Biological Products, (No Diagnostic Substances)

Kymera Therapeutics, Inc.

KYMR Clue Score27

United States Fiscal year ends December CIK 0001815442 Results filed 29 Oct 2026

Add to watchlist

What the insiders did Net selling

Individual transactions

2

Insider

Date

Role

Action

Shares

Price

Amount

Baker Bros. Advisors LP

11 Dec 2025

Director

Buy indirect

1,838,621

$86.00

$158.12M

Baker Bros. Advisors LP

11 Dec 2025

Director

Buy indirect

167,192

$86.00

$14.38M

Showing 250 of 267 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 61

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 4

Sales on a Rule 10b5-1 plan 132

Sales straight out of an exercise 86

Sales at will 42

Transactions with no price 0

Shares from compensation/vesting 844,557

History held since 21 Aug 2020